nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—CYP3A4—Temozolomide—brain cancer	0.293	0.417	CbGbCtD
Silodosin—CYP3A4—Lomustine—brain cancer	0.249	0.355	CbGbCtD
Silodosin—ABCB1—Etoposide—brain cancer	0.1	0.143	CbGbCtD
Silodosin—CYP3A4—Etoposide—brain cancer	0.0602	0.0857	CbGbCtD
Silodosin—Swollen tongue—Etoposide—brain cancer	0.0138	0.0595	CcSEcCtD
Silodosin—Hepatic function abnormal—Procarbazine—brain cancer	0.00695	0.03	CcSEcCtD
Silodosin—Vascular purpura—Procarbazine—brain cancer	0.00679	0.0293	CcSEcCtD
Silodosin—Purpura—Procarbazine—brain cancer	0.0063	0.0272	CcSEcCtD
Silodosin—Jaundice—Procarbazine—brain cancer	0.00456	0.0197	CcSEcCtD
Silodosin—Breast disorder—Hydroxyurea—brain cancer	0.00424	0.0183	CcSEcCtD
Silodosin—Vascular purpura—Temozolomide—brain cancer	0.0041	0.0177	CcSEcCtD
Silodosin—Nasal congestion—Temozolomide—brain cancer	0.00403	0.0174	CcSEcCtD
Silodosin—Purpura—Temozolomide—brain cancer	0.00381	0.0165	CcSEcCtD
Silodosin—Liver function test abnormal—Carmustine—brain cancer	0.00351	0.0152	CcSEcCtD
Silodosin—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00342	0.0148	CcSEcCtD
Silodosin—Breast disorder—Temozolomide—brain cancer	0.00332	0.0143	CcSEcCtD
Silodosin—Syncope—Procarbazine—brain cancer	0.00328	0.0142	CcSEcCtD
Silodosin—Loss of consciousness—Procarbazine—brain cancer	0.00321	0.0139	CcSEcCtD
Silodosin—Dry mouth—Procarbazine—brain cancer	0.00304	0.0132	CcSEcCtD
Silodosin—Angiopathy—Hydroxyurea—brain cancer	0.00295	0.0127	CcSEcCtD
Silodosin—Shock—Procarbazine—brain cancer	0.00294	0.0127	CcSEcCtD
Silodosin—Erectile dysfunction—Temozolomide—brain cancer	0.00292	0.0126	CcSEcCtD
Silodosin—Tachycardia—Procarbazine—brain cancer	0.00291	0.0126	CcSEcCtD
Silodosin—Nausea—Lomustine—brain cancer	0.00279	0.0121	CcSEcCtD
Silodosin—Hypotension—Procarbazine—brain cancer	0.00279	0.012	CcSEcCtD
Silodosin—Insomnia—Procarbazine—brain cancer	0.0027	0.0117	CcSEcCtD
Silodosin—Hepatobiliary disease—Temozolomide—brain cancer	0.00267	0.0116	CcSEcCtD
Silodosin—Sinusitis—Temozolomide—brain cancer	0.00265	0.0115	CcSEcCtD
Silodosin—Gastrointestinal pain—Procarbazine—brain cancer	0.00244	0.0105	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00239	0.0103	CcSEcCtD
Silodosin—Urticaria—Procarbazine—brain cancer	0.00237	0.0102	CcSEcCtD
Silodosin—Abdominal pain—Procarbazine—brain cancer	0.00236	0.0102	CcSEcCtD
Silodosin—Cardiac disorder—Temozolomide—brain cancer	0.00236	0.0102	CcSEcCtD
Silodosin—Angiopathy—Temozolomide—brain cancer	0.0023	0.00996	CcSEcCtD
Silodosin—Mental disorder—Carmustine—brain cancer	0.0023	0.00995	CcSEcCtD
Silodosin—Immune system disorder—Temozolomide—brain cancer	0.00229	0.00991	CcSEcCtD
Silodosin—Mediastinal disorder—Temozolomide—brain cancer	0.00229	0.00989	CcSEcCtD
Silodosin—Nervous system disorder—Hydroxyurea—brain cancer	0.00226	0.00979	CcSEcCtD
Silodosin—Skin disorder—Hydroxyurea—brain cancer	0.00224	0.00969	CcSEcCtD
Silodosin—Mental disorder—Temozolomide—brain cancer	0.00222	0.00961	CcSEcCtD
Silodosin—Jaundice—Etoposide—brain cancer	0.00221	0.00953	CcSEcCtD
Silodosin—Asthenia—Procarbazine—brain cancer	0.00214	0.00925	CcSEcCtD
Silodosin—Hepatobiliary disease—Etoposide—brain cancer	0.00214	0.00925	CcSEcCtD
Silodosin—Pruritus—Procarbazine—brain cancer	0.00211	0.00912	CcSEcCtD
Silodosin—Diarrhoea—Procarbazine—brain cancer	0.00204	0.00882	CcSEcCtD
Silodosin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00199	0.00862	CcSEcCtD
Silodosin—Dizziness—Procarbazine—brain cancer	0.00197	0.00853	CcSEcCtD
Silodosin—Palpitations—Temozolomide—brain cancer	0.00195	0.00844	CcSEcCtD
Silodosin—Cardiac disorder—Etoposide—brain cancer	0.00189	0.00815	CcSEcCtD
Silodosin—Rash—Procarbazine—brain cancer	0.00188	0.00813	CcSEcCtD
Silodosin—Dermatitis—Procarbazine—brain cancer	0.00188	0.00812	CcSEcCtD
Silodosin—Headache—Procarbazine—brain cancer	0.00187	0.00808	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00187	0.00808	CcSEcCtD
Silodosin—Angiopathy—Etoposide—brain cancer	0.00184	0.00797	CcSEcCtD
Silodosin—Dry mouth—Temozolomide—brain cancer	0.00184	0.00795	CcSEcCtD
Silodosin—Immune system disorder—Etoposide—brain cancer	0.00183	0.00793	CcSEcCtD
Silodosin—Mediastinal disorder—Etoposide—brain cancer	0.00183	0.00791	CcSEcCtD
Silodosin—Tachycardia—Carmustine—brain cancer	0.00182	0.00787	CcSEcCtD
Silodosin—Nausea—Procarbazine—brain cancer	0.00177	0.00766	CcSEcCtD
Silodosin—Nervous system disorder—Temozolomide—brain cancer	0.00177	0.00764	CcSEcCtD
Silodosin—Skin disorder—Temozolomide—brain cancer	0.00175	0.00757	CcSEcCtD
Silodosin—Hypotension—Carmustine—brain cancer	0.00174	0.00754	CcSEcCtD
Silodosin—Insomnia—Carmustine—brain cancer	0.00169	0.0073	CcSEcCtD
Silodosin—Asthenia—Hydroxyurea—brain cancer	0.00166	0.00716	CcSEcCtD
Silodosin—Insomnia—Temozolomide—brain cancer	0.00163	0.00705	CcSEcCtD
Silodosin—Gastrointestinal disorder—Carmustine—brain cancer	0.00161	0.00696	CcSEcCtD
Silodosin—Diarrhoea—Hydroxyurea—brain cancer	0.00158	0.00683	CcSEcCtD
Silodosin—Gastrointestinal disorder—Temozolomide—brain cancer	0.00156	0.00673	CcSEcCtD
Silodosin—Loss of consciousness—Etoposide—brain cancer	0.00155	0.00672	CcSEcCtD
Silodosin—Dizziness—Hydroxyurea—brain cancer	0.00153	0.0066	CcSEcCtD
Silodosin—Gastrointestinal pain—Carmustine—brain cancer	0.00153	0.0066	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.0015	0.00646	CcSEcCtD
Silodosin—Abdominal pain—Carmustine—brain cancer	0.00148	0.00638	CcSEcCtD
Silodosin—Gastrointestinal pain—Temozolomide—brain cancer	0.00147	0.00637	CcSEcCtD
Silodosin—Rash—Hydroxyurea—brain cancer	0.00146	0.00629	CcSEcCtD
Silodosin—Dermatitis—Hydroxyurea—brain cancer	0.00145	0.00629	CcSEcCtD
Silodosin—Headache—Hydroxyurea—brain cancer	0.00145	0.00625	CcSEcCtD
Silodosin—Urticaria—Temozolomide—brain cancer	0.00143	0.00619	CcSEcCtD
Silodosin—Abdominal pain—Temozolomide—brain cancer	0.00143	0.00616	CcSEcCtD
Silodosin—Tachycardia—Etoposide—brain cancer	0.00141	0.00609	CcSEcCtD
Silodosin—Skin disorder—Etoposide—brain cancer	0.0014	0.00606	CcSEcCtD
Silodosin—Nausea—Hydroxyurea—brain cancer	0.00137	0.00593	CcSEcCtD
Silodosin—Hypotension—Etoposide—brain cancer	0.00135	0.00583	CcSEcCtD
Silodosin—Asthenia—Carmustine—brain cancer	0.00134	0.00579	CcSEcCtD
Silodosin—Asthenia—Temozolomide—brain cancer	0.00129	0.00559	CcSEcCtD
Silodosin—Diarrhoea—Carmustine—brain cancer	0.00128	0.00552	CcSEcCtD
Silodosin—Pruritus—Temozolomide—brain cancer	0.00128	0.00552	CcSEcCtD
Silodosin—Gastrointestinal disorder—Etoposide—brain cancer	0.00125	0.00539	CcSEcCtD
Silodosin—Dizziness—Carmustine—brain cancer	0.00123	0.00533	CcSEcCtD
Silodosin—Diarrhoea—Temozolomide—brain cancer	0.00123	0.00533	CcSEcCtD
Silodosin—Dizziness—Temozolomide—brain cancer	0.00119	0.00516	CcSEcCtD
Silodosin—Gastrointestinal pain—Etoposide—brain cancer	0.00118	0.0051	CcSEcCtD
Silodosin—Rash—Carmustine—brain cancer	0.00118	0.00509	CcSEcCtD
Silodosin—Dermatitis—Carmustine—brain cancer	0.00118	0.00508	CcSEcCtD
Silodosin—Headache—Carmustine—brain cancer	0.00117	0.00505	CcSEcCtD
Silodosin—Urticaria—Etoposide—brain cancer	0.00115	0.00496	CcSEcCtD
Silodosin—Abdominal pain—Etoposide—brain cancer	0.00114	0.00493	CcSEcCtD
Silodosin—Rash—Temozolomide—brain cancer	0.00114	0.00492	CcSEcCtD
Silodosin—Dermatitis—Temozolomide—brain cancer	0.00114	0.00491	CcSEcCtD
Silodosin—Headache—Temozolomide—brain cancer	0.00113	0.00488	CcSEcCtD
Silodosin—Nausea—Carmustine—brain cancer	0.00111	0.00479	CcSEcCtD
Silodosin—Nausea—Temozolomide—brain cancer	0.00107	0.00463	CcSEcCtD
Silodosin—Asthenia—Etoposide—brain cancer	0.00104	0.00448	CcSEcCtD
Silodosin—Pruritus—Etoposide—brain cancer	0.00102	0.00441	CcSEcCtD
Silodosin—Diarrhoea—Etoposide—brain cancer	0.000988	0.00427	CcSEcCtD
Silodosin—Dizziness—Etoposide—brain cancer	0.000954	0.00413	CcSEcCtD
Silodosin—Rash—Etoposide—brain cancer	0.00091	0.00393	CcSEcCtD
Silodosin—Dermatitis—Etoposide—brain cancer	0.000909	0.00393	CcSEcCtD
Silodosin—Headache—Etoposide—brain cancer	0.000904	0.00391	CcSEcCtD
Silodosin—Nausea—Etoposide—brain cancer	0.000857	0.00371	CcSEcCtD
Silodosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00079	0.012	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000765	0.0116	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—SMO—brain cancer	0.000675	0.0103	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (12/13) signalling events—VAV1—brain cancer	0.000601	0.00912	CbGpPWpGaD
Silodosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000525	0.00797	CbGpPWpGaD
Silodosin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000502	0.00762	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (12/13) signalling events—VAV1—brain cancer	0.000498	0.00757	CbGpPWpGaD
Silodosin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000495	0.00752	CbGpPWpGaD
Silodosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000468	0.0071	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CYP2C9—brain cancer	0.000466	0.00708	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (12/13) signalling events—VAV1—brain cancer	0.000443	0.00672	CbGpPWpGaD
Silodosin—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000426	0.00647	CbGpPWpGaD
Silodosin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000407	0.00618	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—BSG—brain cancer	0.000396	0.00602	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—PTCH2—brain cancer	0.000392	0.00595	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—TRPC6—brain cancer	0.000386	0.00586	CbGpPWpGaD
Silodosin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000378	0.00574	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000345	0.00524	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—OR4C12—brain cancer	0.000344	0.00522	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—OR14C36—brain cancer	0.000344	0.00522	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—IDH1—brain cancer	0.000341	0.00518	CbGpPWpGaD
Silodosin—ADRA1B—AMPK Signaling—PIK3CG—brain cancer	0.000338	0.00514	CbGpPWpGaD
Silodosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000327	0.00497	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—PTCH2—brain cancer	0.000325	0.00494	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—TRPC6—brain cancer	0.00032	0.00486	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—OR4C12—brain cancer	0.000312	0.00474	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—OR14C36—brain cancer	0.000312	0.00474	CbGpPWpGaD
Silodosin—ADRA1A—AMPK Signaling—PIK3CG—brain cancer	0.000301	0.00456	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—PTCH2—brain cancer	0.000289	0.00439	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000287	0.00435	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—OR4C12—brain cancer	0.000285	0.00433	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—OR14C36—brain cancer	0.000285	0.00433	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—TRPC6—brain cancer	0.000285	0.00432	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—RELA—brain cancer	0.000281	0.00426	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000278	0.00421	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—ENO2—brain cancer	0.000269	0.00409	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—OR4C12—brain cancer	0.000259	0.00393	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—OR14C36—brain cancer	0.000259	0.00393	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000254	0.00386	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—OR14C36—brain cancer	0.000253	0.00385	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—OR4C12—brain cancer	0.000253	0.00385	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—OR14C36—brain cancer	0.00023	0.00349	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—OR4C12—brain cancer	0.00023	0.00349	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000223	0.00339	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000216	0.00328	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000213	0.00324	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—SHH—brain cancer	0.000202	0.00307	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PTCH2—brain cancer	0.000201	0.00305	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—EGFR—brain cancer	0.000193	0.00294	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—SMO—brain cancer	0.000191	0.00291	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—PTCH1—brain cancer	0.000191	0.00291	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000186	0.00283	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—OR14C36—brain cancer	0.000184	0.0028	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—OR4C12—brain cancer	0.000184	0.0028	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000177	0.00268	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—ABR—brain cancer	0.000174	0.00264	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—SHH—brain cancer	0.000168	0.00254	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PTCH2—brain cancer	0.000167	0.00253	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP2C9—brain cancer	0.000161	0.00244	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—PTCH1—brain cancer	0.000159	0.00241	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—SMO—brain cancer	0.000159	0.00241	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—ABR—brain cancer	0.000158	0.0024	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DTX2—brain cancer	0.000157	0.00238	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000155	0.00235	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—OR4C12—brain cancer	0.000153	0.00232	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—OR14C36—brain cancer	0.000153	0.00232	CbGpPWpGaD
Silodosin—ADRA1B—AMPK Signaling—TP53—brain cancer	0.000153	0.00232	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000149	0.00227	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—SHH—brain cancer	0.000149	0.00226	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PTCH2—brain cancer	0.000148	0.00225	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—ABR—brain cancer	0.000144	0.00219	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—SMO—brain cancer	0.000141	0.00214	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—PTCH1—brain cancer	0.000141	0.00214	CbGpPWpGaD
Silodosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.00014	0.00212	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—BSG—brain cancer	0.000137	0.00208	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—OR4C12—brain cancer	0.000136	0.00206	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—OR14C36—brain cancer	0.000136	0.00206	CbGpPWpGaD
Silodosin—ADRA1A—AMPK Signaling—TP53—brain cancer	0.000136	0.00206	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—ABR—brain cancer	0.000131	0.00199	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DTX2—brain cancer	0.00013	0.00198	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—ABR—brain cancer	0.000128	0.00195	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—PIK3CG—brain cancer	0.000124	0.00188	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000122	0.00186	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—IL2—brain cancer	0.000122	0.00185	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00012	0.00182	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.00012	0.00182	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTCH2—brain cancer	0.000119	0.0018	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000119	0.0018	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—IDH1—brain cancer	0.000118	0.00179	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ABR—brain cancer	0.000116	0.00177	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DTX2—brain cancer	0.000116	0.00175	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HES5—brain cancer	0.000115	0.00175	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—STRADA—brain cancer	0.000112	0.0017	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00011	0.00167	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—TRPC6—brain cancer	0.00011	0.00167	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000105	0.0016	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—VEGFA—brain cancer	0.000104	0.00157	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—SHH—brain cancer	0.000104	0.00157	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—TRPC6—brain cancer	9.99e-05	0.00152	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTCH2—brain cancer	9.86e-05	0.0015	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—SMO—brain cancer	9.82e-05	0.00149	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PTCH1—brain cancer	9.82e-05	0.00149	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HES5—brain cancer	9.55e-05	0.00145	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ABR—brain cancer	9.32e-05	0.00142	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ENO2—brain cancer	9.3e-05	0.00141	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—STRADA—brain cancer	9.27e-05	0.00141	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—TRPC6—brain cancer	9.13e-05	0.00139	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.08e-05	0.00138	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GLI2—brain cancer	9e-05	0.00137	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	8.84e-05	0.00134	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTCH2—brain cancer	8.76e-05	0.00133	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—SHH—brain cancer	8.6e-05	0.00131	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	8.55e-05	0.0013	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HES5—brain cancer	8.48e-05	0.00129	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GLI1—brain cancer	8.46e-05	0.00129	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—TRPC6—brain cancer	8.29e-05	0.00126	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—VAV1—brain cancer	8.24e-05	0.00125	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STRADA—brain cancer	8.23e-05	0.00125	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PTCH1—brain cancer	8.15e-05	0.00124	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—SMO—brain cancer	8.15e-05	0.00124	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—TRPC6—brain cancer	8.11e-05	0.00123	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SUFU—brain cancer	8.02e-05	0.00122	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GFAP—brain cancer	7.74e-05	0.00118	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ABR—brain cancer	7.74e-05	0.00117	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—SHH—brain cancer	7.64e-05	0.00116	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—VAV1—brain cancer	7.48e-05	0.00114	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GLI2—brain cancer	7.47e-05	0.00113	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—TRPC6—brain cancer	7.36e-05	0.00112	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HEY1—brain cancer	7.34e-05	0.00111	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	7.34e-05	0.00111	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—SMO—brain cancer	7.24e-05	0.0011	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PTCH1—brain cancer	7.24e-05	0.0011	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DLL1—brain cancer	7.2e-05	0.00109	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.14e-05	0.00108	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GLI1—brain cancer	7.03e-05	0.00107	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ABR—brain cancer	6.87e-05	0.00104	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—VAV1—brain cancer	6.84e-05	0.00104	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SUFU—brain cancer	6.66e-05	0.00101	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.64e-05	0.00101	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GLI2—brain cancer	6.64e-05	0.00101	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	6.52e-05	0.000989	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GFAP—brain cancer	6.43e-05	0.000976	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GLI1—brain cancer	6.24e-05	0.000948	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—VAV1—brain cancer	6.21e-05	0.000943	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SHH—brain cancer	6.12e-05	0.000929	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HEY1—brain cancer	6.09e-05	0.000925	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	6.08e-05	0.000923	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP2C9—brain cancer	6e-05	0.000911	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DLL1—brain cancer	5.97e-05	0.000907	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SUFU—brain cancer	5.92e-05	0.000898	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TRPC6—brain cancer	5.9e-05	0.000896	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.87e-05	0.000891	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.81e-05	0.000882	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SMO—brain cancer	5.8e-05	0.000881	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTCH1—brain cancer	5.8e-05	0.000881	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GFAP—brain cancer	5.71e-05	0.000867	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—VAV1—brain cancer	5.52e-05	0.000838	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HEY1—brain cancer	5.41e-05	0.000822	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DLL1—brain cancer	5.31e-05	0.000806	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CG—brain cancer	5.23e-05	0.000795	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.11e-05	0.000777	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—BSG—brain cancer	5.1e-05	0.000774	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SHH—brain cancer	5.08e-05	0.000771	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TRPC6—brain cancer	4.9e-05	0.000744	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SMO—brain cancer	4.82e-05	0.000731	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTCH1—brain cancer	4.82e-05	0.000731	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CG—brain cancer	4.75e-05	0.000722	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.71e-05	0.000715	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOTCH2—brain cancer	4.64e-05	0.000704	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.6e-05	0.000699	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SHH—brain cancer	4.51e-05	0.000685	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VAV1—brain cancer	4.42e-05	0.000671	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—IDH1—brain cancer	4.39e-05	0.000666	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TRPC6—brain cancer	4.35e-05	0.000661	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	4.34e-05	0.00066	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTCH1—brain cancer	4.28e-05	0.000649	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SMO—brain cancer	4.28e-05	0.000649	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CG—brain cancer	4.27e-05	0.000648	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	3.94e-05	0.000599	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.86e-05	0.000587	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	3.86e-05	0.000586	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	3.85e-05	0.000585	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HES1—brain cancer	3.8e-05	0.000577	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP2C9—brain cancer	3.7e-05	0.000561	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—IL2—brain cancer	3.68e-05	0.000559	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VAV1—brain cancer	3.67e-05	0.000557	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	3.62e-05	0.00055	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SPP1—brain cancer	3.51e-05	0.000534	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	3.5e-05	0.000532	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ENO2—brain cancer	3.47e-05	0.000526	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	3.42e-05	0.000519	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL2—brain cancer	3.34e-05	0.000508	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VAV1—brain cancer	3.26e-05	0.000495	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IRS2—brain cancer	3.18e-05	0.000483	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HES1—brain cancer	3.16e-05	0.000479	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—BSG—brain cancer	3.14e-05	0.000477	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—IL2—brain cancer	3.06e-05	0.000464	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	3.01e-05	0.000456	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SPP1—brain cancer	2.92e-05	0.000443	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	2.81e-05	0.000426	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APC—brain cancer	2.81e-05	0.000426	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HES1—brain cancer	2.8e-05	0.000426	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL2—brain cancer	2.78e-05	0.000421	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—IL2—brain cancer	2.71e-05	0.000412	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—IDH1—brain cancer	2.7e-05	0.00041	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	2.67e-05	0.000405	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS2—brain cancer	2.64e-05	0.000401	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SPP1—brain cancer	2.59e-05	0.000393	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EGFR—brain cancer	2.56e-05	0.000388	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL2—brain cancer	2.47e-05	0.000374	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS2—brain cancer	2.34e-05	0.000356	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APC—brain cancer	2.33e-05	0.000354	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	2.33e-05	0.000354	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RELA—brain cancer	2.19e-05	0.000333	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ERBB2—brain cancer	2.18e-05	0.000331	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ENO2—brain cancer	2.14e-05	0.000324	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EGFR—brain cancer	2.12e-05	0.000322	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APC—brain cancer	2.07e-05	0.000314	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	2.07e-05	0.000314	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL2—brain cancer	1.98e-05	0.0003	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCND1—brain cancer	1.93e-05	0.000292	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	1.91e-05	0.00029	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EGFR—brain cancer	1.89e-05	0.000286	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RELA—brain cancer	1.82e-05	0.000276	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ERBB2—brain cancer	1.81e-05	0.000275	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—brain cancer	1.68e-05	0.000255	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—STAT3—brain cancer	1.66e-05	0.000252	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL2—brain cancer	1.64e-05	0.000249	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RELA—brain cancer	1.62e-05	0.000246	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ERBB2—brain cancer	1.61e-05	0.000244	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCND1—brain cancer	1.6e-05	0.000243	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CG—brain cancer	1.59e-05	0.000241	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	1.58e-05	0.00024	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MYC—brain cancer	1.54e-05	0.000235	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EGFR—brain cancer	1.51e-05	0.000229	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL2—brain cancer	1.46e-05	0.000221	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCND1—brain cancer	1.42e-05	0.000216	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	1.41e-05	0.000214	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.39e-05	0.000212	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.38e-05	0.00021	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MYC—brain cancer	1.28e-05	0.000195	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—brain cancer	1.27e-05	0.000193	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EGFR—brain cancer	1.25e-05	0.00019	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—brain cancer	1.24e-05	0.000188	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STAT3—brain cancer	1.23e-05	0.000186	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MYC—brain cancer	1.14e-05	0.000173	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EGFR—brain cancer	1.11e-05	0.000169	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—brain cancer	1.05e-05	0.00016	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CG—brain cancer	9.8e-06	0.000149	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—brain cancer	9.35e-06	0.000142	CbGpPWpGaD
